69 results on '"Masamoto, Yosuke"'
Search Results
2. CCL1 As a Biomarker of Engraftment Syndrome of Hematological Stem Cell Transplantation
3. MO49-4 Obinutuzumab and reduced bendamustine for elderly follicular lymphoma patients: A single institution retrospective study
4. Prompt Initiation of Conventional Chemotherapy to Avoid Early Death in Patients with Newly Diagnosed Acute Promyelocytic Leukemia
5. Aortitis Associated with Prophylactic Short-acting Granulocyte Colony-stimulating Factor Administration: A Case Report and Review of the Literature
6. EVI1 exerts distinct roles in AML via ERG and cyclin D1 promoting a chemoresistant and immune-suppressive environment
7. Toxic shock like syndrome caused by Streptococcus agalactiae bacteremia during treatment for multiple myeloma
8. Verification study on the catheterization of an upper arm vein using the new long peripheral intravenous catheter to reduce catheter failure incidence: A randomized controlled trial
9. Expansion of large granular lymphocytes after autologous hematopoietic stem cell transplantation
10. Isolated relapse of plasma cell leukemia in the central nervous systems: a case report and literature review
11. Acalabrutinib and steroid for autoimmune thrombocytopenia due to relapsed chronic lymphocytic leukemia with severe bone marrow infiltration
12. Bing-Neel Syndrome Successfully Treated with Tirabrutinib
13. A culture platform to study quiescent hematopoietic stem cells following genome editing
14. EVI1 Promotes Immune-Evasive Microenvironment Via Cyclin D1 in Acute Myeloid Leukemia
15. Knockout of HMGA1 Promotes ATRA-Induced Differentiation in MLL-Rearranged Leukemia
16. Cooperative Inhibitory Effect of IDH1 Mutation and ASXL1 Mutation on Normal Myeloid Differentiation
17. Obinutuzumab and reduced bendamustine is effective for elderly patients with follicular lymphoma
18. Clinical characteristics of steroid-responsive but dependent chronic graft-versus-host disease: a multicenter retrospective analysis
19. Long-term follow-up of central nervous system relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
20. Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion
21. Bone marrow involvement is a risk factor for infusion-related reactions in patients with follicular lymphoma treated by obinutuzumab
22. A case of JAK2 V617F positive essential thrombocythemia successfully controlled by imatinib mesylate
23. MO12-4 Clinical management of other iatrogenic immunodeficiency-associated lymphoproliferative disorders
24. Safety verification of a new peripheral intravenous catheter placed in the upper arm vein for administration of drugs with high irritant potential
25. Severe infections and renal dysfunction during immunosuppressive therapy with cyclosporine A for aplastic anemia
26. Heterozygous Dnmt3a R878C induces expansion of quiescent hematopoietic stem cell pool
27. Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis
28. Cerebral toxoplasmosis complicating lymphoplasmacytic lymphoma in partial remission
29. Risk of febrile neutropenia in very elderly patients aged ≥80 years receiving their first cycle of R‐CHOP regimen: a nationwide real‐world study in Japan
30. Severe autoimmune pancytopenia after autologous hematopoietic stem cell transplantation for Hodgkin lymphoma
31. R-GCD regimen in elderly patients with relapsed or refractory aggressive non-Hodgkin’s B-cell lymphoma: a retrospective single-center analysis
32. eIF4B Is a Novel Target of CAMK2G and Promotes Proliferation of Malignant Cells in Myelofibrosis
33. A Nationwide Survey of Lower Risk Myelodysplastic Syndromes in Japan
34. EVI1-Positive AML Cells Show Distinct Features and High Dependency on ETS Transcription Factor ERG
35. Risk of Febrile Neutropenia in Very Elderly Patients Aged ≥80 Years Who Received R-CHOP Regimen: A Nationwide Analysis in Japan
36. High D‐index during mobilization predicts poor mobilization of CD34 + cells after anti‐lymphoma salvage chemotherapy
37. Degenerated mitochondria in leukemic blast appeared as granules on May-Grunwald-Giemsa staining
38. Use of wide-spectrum antimicrobials with blood culture tests during chemotherapy as an accurate marker of febrile neutropenia in the DPC database: A validation study
39. CAMK2G is identified as a novel therapeutic target for myelofibrosis
40. Evi1 upregulates Fbp1 and supports progression of acute myeloid leukemia through pentose phosphate pathway activation
41. Reduced bendamustine for elderly patients with follicular lymphoma
42. Severe cellulitis caused by Achromobacter xylosoxidans after allogeneic hematopoietic stem cell transplantation
43. A retrospective analysis on arteritis after administration of granulocyte colony-stimulating factor
44. Primary prophylaxis with pegfilgrastim during the first cycle of R-CHOP to avoid reduction of dose intensity in elderly patients
45. HMGA1 Is Upregulated in Myelodysplastic Syndromes with Mutation in Pre-mRNA Splicing Genes and Inhibits Leukemia Cell Differentiation
46. Predictors of Glucocorticoid Responsiveness in Multicentric Castleman's Disease
47. GFI1 Is a Downstream Target of EVI1 in Normal Hematopoiesis
48. Hemoglobin and C-reactive protein levels as predictive factors for long-term successful glucocorticoid treatment for multicentric Castleman’s disease
49. Successful treatment of EBV-related lymphoproliferative disease after heart transplantation with autologous hematopoietic stem cell transplantation despite transient heart failure associated with engraftment syndrome
50. Insulin- and Lipopolysaccharide-Mediated Signaling in Adipose Tissue Macrophages Regulates Postprandial Glycemia through Akt-mTOR Activation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.